-33 Red bar: tonsil tumour samples, n =14 x2 Green bar: tonsil normal samples, n = 9 x2 A B Supplementary Figure 1. A)Unsupervised HCL analysis was used.

Slides:



Advertisements
Similar presentations
Supplementary Fig. 1. Transcriptome analysis of MENX-associated pituitary adenomas and and comparison with human studies. Control samples from wild-type.
Advertisements

Supplementary Figure 1. MiR-30a binding sites in NOTCH1 and NOTCH2 3’UTRs. The miR-30a binding site in NOTCH1 (nucleotides of the human 3’UTR.
MicroRNA implication in urinary bladder cancer A. Zaravinos 1, J. Radojicic 3, G.I. Lambrou 2, D. Volanis 1,4, D. Delakas 4, E.N. Stathopoulos 3, D.A.
Expression profile of oncomiRs and tumor-suppressor miRs in urothelial carcinoma of the bladder Apostolos Zaravinos 1, George I. Lambrou 2, Jelena Radojicic.
Supplementary Figure 1 Supplementary Figure 1. Representative micrographs of migration and invasion assays. miR-452 or si-WWP1 transfectants inhibited.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Germline Epigenetic Regulation of KILLIN in Cowden.
Identification of a Novel Substance P–Neurokinin-1 Receptor MicroRNA-221-5p Inflammatory Network in Human Colonic Epithelial Cells  Kai Fang, Aristea.
Volume 342, Issue 1, Pages (January 2014)
Molecular Therapy - Nucleic Acids
Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a Cell Physiol Biochem.
Supplementary Figure 1: Clinical parameters of the breast tumor samples used for the study. IDC = Invasive ductal carcinoma and ILC= Invasive Lobular.
A B C D Rao et al., 2012; Supplementary Figure S1 p = 0.03 p = NS
Figure 1 miRNA expression in multiple sclerosis lesions
Cell Physiol Biochem 2017;44:1867– DOI: /
Figure S1 C A B D E F G H I MHCC-97H Control NC pCDH kDa
A Strategy to Find Suitable Reference Genes for miRNA Quantitative PCR Analysis and Its Application to Cervical Specimens  Iris Babion, Barbara C. Snoek,
Volume 145, Issue 4, Pages e9 (October 2013)
Volume 135, Issue 5, Pages e24 (November 2008)
Bongyong Lee, Joseph Mazar, Muhammad N
Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma  Jun Wang, MD, PhD, Zhi Li, MD, PhD,
Psoriasis Skin Inflammation-Induced microRNA-26b Targets NCEH1 in Underlying Subcutaneous Adipose Tissue  Louisa Cheung, Rachel M. Fisher, Natalia Kuzmina,
Volume 145, Issue 4, Pages e9 (October 2013)
Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway by María J. Bueno, Marta Gómez de Cedrón, Gonzalo Gómez-López, Ignacio Pérez de.
UHRF1 is regulated by miR-9 in colorectal cancer
Volume 136, Issue 2, Pages (February 2009)
MicroRNA-17/20a/106a modulate macrophage inflammatory responses through targeting signal-regulatory protein α  Dihan Zhu, MSc, Chaoyun Pan, MSc, Limin.
Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1 by Vanessa J. Craig, Sergio B.
Volume 135, Issue 1, Pages (July 2008)
Hierarchical Rules for Argonaute Loading in Drosophila
Revealing Global Regulatory Perturbations across Human Cancers
Figure S2 Supplementary data a b CCA1 CCA2 CCA4 CCA3 CCA5 EGFR HER2
Volume 13, Issue 6, Pages (June 2013)
Identification of miR‐499 targets
Molecular Therapy - Nucleic Acids
CHK1 downregulation upon ERG overexpression.
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
Epigenetic regulation of miR-193b in liposarcomagenesis.
Microarray analysis of phospho-Twist1–responsive genes.
MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2  Ning Xu, Petter Brodin, Tianling Wei, Florian.
Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells  Tomer Halevy, Christian Czech, Nissim.
Revealing Global Regulatory Perturbations across Human Cancers
Molecular Therapy - Nucleic Acids
Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang  Molecular Therapy 
HDAC1 positively regulates the abundance of miRNAs.
Alterations in mRNA 3′ UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington’s Disease Brains  Lindsay Romo, Ami Ashar-Patel, Edith.
Volume 18, Issue 6, Pages (December 2015)
Let-7-Complex MicroRNAs Regulate the Temporal Identity of Drosophila Mushroom Body Neurons via chinmo  Yen-Chi Wu, Ching-Huan Chen, Adam Mercer, Nicholas S.
ERα directly binds to pri‐miR‐22
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation  Dimitrios Iliopoulos, Heather A. Hirsch,
A single nucleotide polymorphism in a miR-1302 binding site in CGA increases the risk of idiopathic male infertility  Hao Zhang, Ph.D., Yunqiang Liu,
Volume 4, Issue 1, Pages (July 2013)
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Rational Design of Therapeutic siRNAs: Minimizing Off-targeting Potential to Improve the Safety of RNAi Therapy for Huntington's Disease  Ryan L Boudreau,
Molecular Therapy - Nucleic Acids
Cell system for following and quantifying single-gene transcription in fixed and living cells. Cell system for following and quantifying single-gene transcription.
The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2  Cheng-Cao Sun, Ling Zhang, Guang.
Comparison ofMyc-induced zebrafish liver tumors with different stages of human HCC and seven mouse HCC models. Comparison ofMyc-induced zebrafish liver.
Volume 24, Issue 10, Pages (October 2016)
MiR-431-5p directly targets RAF1 and is negatively correlated to RAF1 expression (A) The predicted binding sites of miR-431-5p and RAF1 3′-UTR, and mutant.
FBXL19-AS1 acts as a sponge of miR-431-5p in lung cancer (A) The predicted binding sites of FBXL19-AS1 and miR-431-5p, and the mutant sites in mutant-type.
Volume 22, Issue 9, Pages (September 2014)
Boyan Bonev, Peter Stanley, Nancy Papalopulu  Cell Reports 
MiR-206 regulates the expression of BDNF via three seed matches on its 3′-UTR. miR-206 regulates the expression of BDNF via three seed matches on its 3′-UTR.
Correlation of miR-21 expression levels with DEGs in 28 bladder cancer cell lines. Correlation of miR-21 expression levels with DEGs in 28 bladder cancer.
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Targeting DCLK1 by miRNA-137.
Transcripts enriched and depleted in NB TICs compared with SKPs and other tumor tissues. Transcripts enriched and depleted in NB TICs compared with SKPs.
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
Molecular Therapy - Nucleic Acids
Hierarchical Rules for Argonaute Loading in Drosophila
Presentation transcript:

-33 Red bar: tonsil tumour samples, n =14 x2 Green bar: tonsil normal samples, n = 9 x2 A B Supplementary Figure 1. A)Unsupervised HCL analysis was used to generate a heat map for the expression of miRNAs in tonsillar tumour and adjacent normal tissue. This indicated that HCL was able to cluster the tumor and normal tissue into two distinct biological groups. Blue represent reduced expression while yellow represents high expression. The upper limits for both fold change was -3 and +3. A)B) PCA analysis further indicate that the tumor samples cluster more closely together (red dots) than the normal tissues (green dots). Interestingly, cell lines (yellow dots) did not entirely cluster with the tumor samples. Tumor tissue Normal adjacent tissue

Supplementary Figure 2. Schematic view of the miR-21 and miR-499 miRNA binding sites on the 3’UTR of PDCD4. NB: Drawing not to scale 3’ UTR: 1.9 kbORF: 1.41 kb.5’..GAAAGUUAUUUCUUUGUCUUAAA... | | | | | | | | | | 3’ AAUUUGUAGUGACGUUCAGAAUU 5’..GGAACAUACUGAUUGGUCUUAAA... | | | | | | | | | | | | 3’ AUUUGUAGUGACGUUCAGAAUU miR-499 ( ) miR-499 ( ) miR-499 (17-13) 5’.. UA UAAGAACUCUUGC AGUCUUAG... | | | | | | | | | | 3‘AAUUUGUAGUGACGU..UCAGAAUU miR-21 ( ) 5’.. AAGUGGAAUAUUCUAAUAAGCUA... | | | | | | | 3’ AGUUGUAGUCAGACUAUUCGAU

miR-21 PDCD HEK 293 SCC029b SCC089SCC099SCC003 Expression of miR-21 and PDCD4 in various HNSCC cell lines Supplementary Figure 3. Expression of miR-21 and PDCD4 in various HNSCC cell lines. qPCR was utilized to measure expression of both the miRNA and the target gene. All reactions were performed in triplicate (n=3). There is a inverse relationship between miR-21 and PDCD4 in HNSCC cancer cells.

miR-21 PDCD Relative expression of miR-21 and PDCD4 in miR-21 depleted SCC003 cells at 48 hrs. miR-21 LNA antisenseLNA antisense control Supplementary Figure 4. The expression of PDCD4 in miR-21 depleted SCC003 cells. The addition of a miR-21 LNA antisense reduced PDCD4 RNA expression by 15 fold at 48h. Fold change in PDCD4 expression was measured relative to cells transfected with the LNA antisense controls. The formula use was 2 -ΔΔCt for n=3

RNA expression of PDCD4 in SCC03 cells co-transfected with miRNAs and PDCD4 constructs with and without the 3’UTR Supplementary Figure 5. RNA expression of PDCD4 in SCC03 cells transfected with PDCD4 constructs with and without the 3’UTR. These cells were also co-transfected with either miR-21, miR-499 alone or in combination. PDCD4 levels were normalize to cells transfected with the pre-miR control and fold expression calculated using 2 ΔΔCt for n=3. PDCD4 was only down regulated when the 3’UTR was present.

Expression of miR-21 raw Ct value in transfected 293 cells AB Expression of miR-499 raw Ct value in transfected 293 cells C 24hrs48hrs Pre-miR-21 24hrs48hrs Pre-miR-499 Expression of PDCD4 RNA in SCC03 cancer cells overexpressing miR-21/499 (n=3) Supplementary Figure cells were transfected with pre-miR-21, pre-miR-499 alone or in combination. The control pre-miR is a scramble sequence. Transfection levels were then measured using qPCR at 24, 48, 72 and 96hrs. A). Expression levels of miR-21 in miR-21 transfected cells. B). miR-499 expression levels in cells transfected with miR-499. C). Regulation of PDCD4 RNA in SCC03 cells overexpressing miR-21 or miR-499 alone or in combination. Fold change in PDCD4 were expressed relative to control cells containing the Pre-miR control and calculated using 2 ΔΔCt for n=3. Similar to the results in figure 4a, miR-21 was able to down-regulate PDCD4 at 24 hrs while miR-499 had no effect. At 48hrs however, miR-499 was able to downregulate the target and it appears that miR-21 suppression was reduced.